Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 may trigger sudden temporary hair loss.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The study created a new hair loss treatment paste that regrows hair faster and with fewer side effects than minoxidil alone.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Trichoscopy helped diagnose and cure a child's hair loss caused by a fungal infection.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Topical Minoxidil is effective for hair loss after COVID-19.

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

Hair transplantation is beneficial if the right patients are chosen and the procedure is done carefully.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

The Cochrane Database published its 5000th review in 2012, covering various health topics and updating conclusions based on new research.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.